Calendar Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 10/12/2025 GMT			5-day change	1st Jan Change
309.10 ^DKK	+3.31%		+1.74%	-50.48%

06:39am	Zealand Pharma to accelerate drug development for obesity, metabolic disease	RE
05:22am	SEB Lowers Novo Nordisk Target Price to 440 Danish Kroner, Reiterates Buy	FW

Chart calendar Novo Nordisk A/S

a48bf98f3e17aff.rqu3UOucOkZP-DW53Kxd9P4T_9MDhehuTaoofNach_0.8ZnnKaz2VCsdjQf2s4EKp51Hvb5mttEZJMQQOJHdsqv89NsDmelJNQ2hDQ~c32d24ab0c1a6bc5cca8bd469ed09a43

Upcoming events on Novo Nordisk A/S

03/02/2026	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
29/04/2026	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
05/08/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
03/11/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
02/02/2027	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Novo Nordisk A/S

14/11/2025	Extraordinary Shareholders Meeting
10/11/2025	American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0174
10/11/2025	American Association for the Study of Liver Diseases Meeting - Poster No:4042
10/11/2025	American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0010
09/11/2025	American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0148
09/11/2025	American Association for the Study of Liver Diseases Meeting - Poster No:3086
08/11/2025	American Association for the Study of Liver Diseases Meeting - Poster No:2625
08/11/2025	American Association for the Study of Liver Diseases Meeting - Poster No:2545
08/11/2025	American Association for the Study of Liver Diseases Meeting - Poster No:2075
08/11/2025	American Association for the Study of Liver Diseases Meeting - Poster No:2570
08/11/2025	American Association for the Study of Liver Diseases Meeting - Poster No:2052
06/11/2025	ObesityWeek - Semaglutide 7.2 mg
06/11/2025	ObesityWeek - ASCVD Risk
06/11/2025	Q3 2025 Earnings Call - London
05/11/2025	ObesityWeek - World Risk of CV
05/11/2025	ObesityWeek - Semaglutide 2.4 mg
05/11/2025	ObesityWeek - Cardiovascular Risk
05/11/2025	ObesityWeek
05/11/2025	ObesityWeek
05/11/2025	ObesityWeek - CagriSema

Past dividends on Novo Nordisk A/S

14/08/2025	Interim Payment 3.75 DKK
27/03/2025	Final Payment 7.9 DKK
14/08/2024	Interim Payment 3.5 DKK
21/03/2024	Final Payment 6.4 DKK
17/08/2023	Interim Payment 6 DKK
23/03/2023	Final Payment 8.15 DKK
11/08/2022	Interim Payment 4.25 DKK
24/03/2022	Final Payment 6.9 DKK
15/08/2021	Interim Payment 3.5 DKK
25/03/2021	Final Payment 5.85 DKK
13/08/2020	Interim Payment 3.25 DKK
26/03/2020	Final Payment 5.35 DKK
15/08/2019	Interim Payment 3 DKK
21/03/2019	Final Payment 5.15 DKK
16/08/2018	Interim Payment 3 DKK
22/03/2018	Final Payment 4.85 DKK
17/08/2017	Interim Payment 3 DKK
23/03/2017	Final Payment 4.6 DKK
11/08/2016	Interim Payment 3 DKK
20/03/2016	Annual 6.4 DKK

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million DKK	Released Forecast Spread	176 954 175 090 1.06%	232 261 228 920 1.46%	290 403 285 429 1.74%	307 594	305 468	328 079
EBITDA Million DKK	Released Forecast Spread	82 171 82 386 -0.26%	111 987 109 530 2.24%	147 446 141 939 3.88%	148 572	146 749	158 985
EBIT Million DKK	Released Forecast Spread	74 809 75 141 -0.44%	102 574 101 255 1.3%	128 339 126 210 1.69%	128 529	127 756	137 989
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	69 062 69 370 -0.44%	104 674 102 184 2.44%	127 191 125 432 1.4%	130 606	127 251	136 513
Net income Million DKK	Released Forecast Spread	55 525 54 785 1.35%	83 683 82 021 2.03%	100 988 100 215 0.77%	102 716	99 650	107 064
EPS DKK	Released Forecast Spread	12,2 12,2 0.25%	18,6 18,3 1.79%	22,6 22,3 1.67%	23,1	22,9	24,7
Announcement Date		01/02/23	31/01/24	05/02/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million DKK	Released Forecast Spread	65 349 63 437 3.01%	68 060 68 563 -0.73%	71 311 71 869 -0.78%	85 683 80 179 6.86%	78 087 78 019 0.09%	76 857 77 114 -0.33%	74 976 77 075 -2.72%	77 281	76 155	81 150	84 090	92 970
EBITDA Million DKK	Released Forecast Spread	34 760 31 300 11.05%	34 779 29 430 18.17%	35 972 36 184 -0.59%	41 935 36 501 14.89%	42 621 40 715 4.68%	38 282 38 965 -1.75%	31 439 34 245 -8.19%	34 667
EBIT Million DKK	Released Forecast Spread	31 846 28 694 10.99%	25 934 27 258 -4.86%	33 822 33 301 1.57%	36 737 32 939 11.53%	38 791 36 740 5.58%	33 449 34 694 -3.59%	23 682 24 684 -4.06%	31 297
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	31 918 28 630 11.48%	25 332 27 740 -8.68%	34 384 33 325 3.18%	35 557 31 943 11.31%	37 033 35 000 5.81%	33 805 34 568 -2.21%	25 517 26 943 -5.29%	33 051
Net income Million DKK	Released Forecast Spread	25 407 23 169 9.66%	20 050 22 116 -9.34%	27 301 26 877 1.58%	28 230 25 743 9.66%	29 034 27 298 6.36%	26 503 27 136 -2.33%	20 006 21 390 -6.47%	26 183	27 736	27 217	28 526	28 833
EPS DKK	Released Forecast Spread	5,68 5,19 9.54%	4,49 4,71 -4.72%	6,12 5,98 2.32%	6,34 5,76 10.06%	6,53 6,15 6.1%	5,96 6,07 -1.87%	4,50 4,59 -1.91%	5,83	6,24	6,12	6,41	6,48
Announcement Date		02/05/24	07/08/24	06/11/24	05/02/25	07/05/25	06/08/25	05/11/25	-	-	-	-	-

Upcoming sector events for Novo Nordisk A/S

05/01/2026	HISAMITSU PHARMACEUTICAL CO., INC.	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
11/01/2026	TILRAY BRANDS, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
15/01/2026	SUPRIYA LIFESCIENCE LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
20/01/2026	JOHNSON & JOHNSON	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
20/01/2026	HANALL BIOPHARMA CO., LTD.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
21/01/2026	LAURUS LABS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
21/01/2026	ALIVUS LIFE SCIENCES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
21/01/2026	TORRENT PHARMACEUTICALS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
22/01/2026	DR. REDDY'S LABORATORIES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
26/01/2026	GRANULES INDIA LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Novo Nordisk A/S

09/12/2025	MEDINCELL S.A.	Q2 2026 Earnings Release
09/12/2025	CENTER LABORATORIES, INC.	November 2025 Sales and Revenue Release
09/12/2025	BORA PHARMACEUTICALS CO., LTD.	November 2025 Sales and Revenue Release
05/12/2025	TTY BIOPHARM COMPANY LIMITED	November 2025 Sales and Revenue Release
30/11/2025	INVENTAGE LAB, INC.	Q3 2025 Earnings Release
27/11/2025	DOTTIKON ES HOLDING AG	Q2 2026 Earnings Release
20/11/2025	CSPC PHARMACEUTICAL GROUP LIMITED	Q3 2025 Earnings Release
14/11/2025	SEQUENT SCIENTIFIC LIMITED	Q2 2026 Earnings Release
14/11/2025	NATCO PHARMA LIMITED	Q2 2026 Earnings Release
14/11/2025	BAVARIAN NORDIC A/S	Q3 2025 Earnings Release